Product NewsLife Sciences

Cell line engineering with CRISPR-Cas9: Screening strategies

20 Oct 2020
Cell line engineering with CRISPR-Cas9: Screening strategies

Once you've run your CRISPR experiment and you have a pool of mixed genotypes, finding clones with the genotypes of interest and determining how many clones you should screen should be your next steps. John Wright, Ph.D, Scientist at Horizon Discovery's Cell Line Engineering Services Group, discusses how to go about this in more detail.

About the company

Revvity Signals logo

Revvity Signals

Revvity Signals offers one of the most comprehensive suites of scientific software in the world. Its powerful informatics solutions are used across a spectrum of industries including Pharma and Biotech, Specialty & Agro-Chemicals, Energy & Petrochemicals, Flavors & Fragrances, Food & Beverage and Electronics. From its internationally recognized flagship ChemDraw® and E-Notebook applications, to its Signals Research Suite (Signals Notebook, Signals VitroVivo and Signals Inventa) to its exclusive TIBCO® Spotfire® partnership that brings scientific data analytics to visual life, no scientific company offers a wider range and more powerful suite of scientific solutions than Revvity Signals.

4.2/5.0
|4 Reviews

Other videos from Revvity Signals

Links